Smithfield Trust’s Qiagen QGEN Stock Holding History

Smithfield Trust’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-267	Closed	-$15K	–	1113
2020 Q4	$15K	Hold	267	–	–	﹤0.01%	739
2020 Q3	$15K	Hold	267	–	–	﹤0.01%	686
2020 Q2	$12K	Buy	+267	New	+$11.9K	﹤0.01%	710

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Smithfield Trust's QGEN Position: Q1 2021 in Review

Smithfield Trust sold out of Qiagen (QGEN) in Q1 2021, closing a stake of 267 shares — an estimated $15K sold.

Smithfield Trust first reported a position in QGEN in Q2 2020 and held it in 3 quarters. The position peaked at $15K in Q4 2020. 274 funds tracked by Wall St. Rank hold QGEN as of Q1 2021.

Smithfield Trust reported no remaining Qiagen position as of Q1 2021 after selling out during the quarter.
Smithfield Trust sold 267 Qiagen shares in Q1 2021, an estimated $15K.
Smithfield Trust first reported a position in Qiagen in Q2 2020 and held it in 3 quarters.
Smithfield Trust's Qiagen position peaked at $15K in Q4 2020.
274 funds tracked by Wall St. Rank held Qiagen as of Q1 2021.

Based on Smithfield Trust's 13F filing for Q1 2021, filed 14 May 2021.